A significant shift in Canadian drug policy has taken place, as the government announce the use of psilocybin mushrooms for therapeutic treatment. Previously, these substances were severely restricted, but a growing body of research suggests they potentially offer benefits for psychological conditions like PTSD. This change represents a substantial